NCT00226044View on ClinicalTrials.gov

Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.

PHASE3CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2017

Conditions

Gastroesophageal RefluxEsophageal AtresiaHernia, Diaphragmatic

Interventions

DRUG

Omeprazole rectally 1mg/kg

A single dose of 1 mg/kg rectally administered omeprazole.

Trial Locations (1)

3015 GD

Erasmus Medical center, Rotterdam

Sponsors

Collaborators (1)

Erasmus Medical Center

All Listed Sponsors

collaborator

Erasmus Medical Center

OTHER

lead

Rijnstate Hospital

OTHER